|
CBX2 expression profile based on
|
BRCA : Breast invasive carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.11191647665878E-83
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.06488884271461E-13 |
| Normal-vs-Stage2 |
5.34189236527619E-52 |
| Normal-vs-Stage3 |
8.07804281099633E-22 |
| Normal-vs-Stage4 |
6.713757E-04 |
| Stage1-vs-Stage2 |
3.96276145059697E-08 |
| Stage1-vs-Stage3 |
3.055473E-02 |
| Stage1-vs-Stage4 |
4.216460E-02 |
| Stage2-vs-Stage3 |
1.277610E-03 |
| Stage2-vs-Stage4 |
6.727045E-01 |
| Stage3-vs-Stage4 |
1.625876E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.20178382663846E-52 |
| Normal-vs-AfricanAmerican |
3.43603587517705E-22 |
| Normal-vs-Asian |
7.54854362191382E-08 |
| Caucasian-vs-AfricanAmerican |
1.23924100430887E-06 |
| Caucasian-vs-Asian |
1.154847E-02 |
| AfricanAmerican-vs-Asian |
6.720375E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.218058E-02 |
| Normal-vs-Female |
6.99117488862311E-83 |
| Male-vs-Female |
3.081220E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.16199553773106E-10 |
| Normal-vs-Age(41-60Yrs) |
2.96836291219068E-43 |
| Normal-vs-Age(61-80Yrs) |
6.31652263764181E-30 |
| Normal-vs-Age(81-100Yrs) |
1.967601E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.955378E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.412753E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.208739E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.777359E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.804088E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.402307E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Pre-menopause |
6.49754941744718E-18 |
| Normal-vs-Peri-menopause |
1.27740816832194E-05 |
| Normal-vs-Post-menopause |
9.17538368648597E-54 |
| Pre-menopause-vs-Peri-menopause |
5.302065E-01 |
| Pre-menopause-vs-Post-menopause |
1.486256E-01 |
| Peri-menopause-vs-Post-menopause |
9.243880E-01 |
|
|
| Subtype descriptions |
| IDC | Infiltrating Ductal Carcinoma |
ILC | Infiltrating Lobular Carcinoma |
| Mixed | Mixed histology |
Mucinous | Mucinous Carcinoma |
| Medullary | Medullary Carcinoma |
Metaplastic | Metaplastic Carcinoma |
| INOS | Infiltrating Carcinoma NOS |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-IDC |
4.63133262460055E-08 |
| Normal-vs-ILC |
1.79407409630512E-75 |
| Normal-vs-Mixed |
1.622462E-02 |
| Normal-vs-Other |
4.816486E-01 |
| Normal-vs-Mucinous |
5.439215E-03 |
| Normal-vs-Metaplastic |
8.760709E-03 |
| Normal-vs-INOS |
NA |
| Normal-vs-Medullary |
1.859401E-03 |
| IDC-vs-ILC/td>
| 4.93085154189087E-36 |
| IDC-vs-Mixed |
6.990705E-02 |
| IDC-vs-Other |
9.937605E-02 |
| IDC-vs-Mucinous |
8.313750E-03 |
| IDC-vs-Metaplastic |
2.441485E-02 |
| IDC-vs-INOS |
NA |
| IDC-vs-Medullary |
1.972910E-01 |
| ILC-vs-Mixed |
5.350489E-01 |
| ILC-vs-Other |
3.68403905647238E-11 |
| ILC-vs-Mucinous |
6.127862E-02 |
| ILC-vs-Metaplastic |
8.538170E-01 |
| ILC-vs-Mixed |
NA |
| ILC-vs-INOS |
7.63766216588169E-07 |
| ILC-vs-Medullary |
2.814623E-02 |
| Mixed-vs-Other |
4.043584E-02 |
| Mixed-vs-Mucinous |
5.617514E-01 |
| Mixed-vs-Metaplastic |
NA |
| Mixed-vs-INOS |
1.866632E-01 |
| Mixed-vs-Medullary |
5.617450E-03 |
| Other-vs-Mucinous |
1.153357E-02 |
| Other-vs-Metaplastic |
NA |
| Other-vs-INOS |
2.967571E-02 |
| Other-vs-Medullary |
9.375167E-02 |
| Mucinous-vs-Metaplastic |
NA |
| Mucinous-vs-INOS |
1.064490E-02 |
| Mucinous-vs-Medullary |
NA |
| Metaplastic-vs-INOS |
5.585390E-02 |
| Metaplastic-vs-Medullary |
NA |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Luminal |
5.23916008109616E-32 |
| Normal-vs-HER2Positive |
2.65731162805529E-07 |
| Normal-vs-TNBC |
6.39729484493448E-28 |
| Luminal-vs-HER2Positive |
5.65120971259752E-05 |
| Luminal-vs-TNBC |
4.22665686455809E-17 |
| HER2Positive-vs-TNBC |
5.438818E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-TP53 mutant |
3.37260495553058E-55 |
| Normal-vs-TP53 nonmutant |
3.96003658288041E-29 |
| TP53 mutant-vs-TP53 nonmutant |
1.30133517180277E-30 |
|
|
| Subtype descriptions |
| TNBC-BL1 | TNBC-Basal like 1 |
TNBC-BL2 | TNBC-Basal like 2 |
| TNBC-LAR | TNBC-luminal androgen receptor |
TNBC-IM | TNBC-immunomodulatory |
| TNBC-MSL | TNBC-mesenchymal stem–like |
TNBC-M | TNBC-mesenchymal |
| TNBC-UNS | TNBC-unspecified |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Luminal |
5.23916008109616E-32 |
| Normal-vs-HER2positive |
2.65731162805529E-07 |
| Normal-vs-TNBC-BL1 |
2.672468E-04 |
| Normal-vs-TNBC-BL2 |
1.574391E-03 |
| Normal-vs-TNBC-LAR |
4.645789E-03 |
| Normal-vs-TNBC-IM |
3.1479518324029E-05 |
| Normal-vs-TNBC-M |
1.84798839227571E-09 |
| Normal-vs-TNBC-MSL |
7.278960E-02 |
| Normal-vs-TNBC-UNS |
1.647920E-04 |
| Luminal-vs-HER2positive |
5.65120971259752E-05 |
| Luminal-vs-TNBC-BL1 |
2.734461E-03 |
| Luminal-vs-TNBC-BL2 |
9.911072E-03 |
| Luminal-vs-TNBC-LAR |
1.629162E-02 |
| Luminal-vs-TNBC-IM |
9.600489E-04 |
| Luminal-vs-TNBC-M |
7.96382600924985E-07 |
| Luminal-vs-TNBC-MSL |
1.802649E-01 |
| Luminal-vs-TNBC-UNS |
1.241918E-02 |
| HER2Positive-vs-TNBC-BL1 |
8.549455E-01 |
| HER2Positive-vs-TNBC-BL2 |
9.041829E-01 |
| HER2Positive-vs-TNBC-LAR |
5.872000E-01 |
| HER2Positive-vs-TNBC-IM |
8.321911E-01 |
| HER2Positive-vs-TNBC-M |
8.410638E-01 |
| HER2Positive-vs-TNBC-MSL |
4.908535E-01 |
| HER2Positive-vs-TNBC-UNS |
1.360513E-01 |
| TNBC-BL1-vs-TNBC-BL2 |
7.876103E-01 |
| TNBC-BL1-vs-TNBC-LAR |
7.069990E-01 |
| TNBC-BL1-vs-TNBC-IM |
7.180267E-01 |
| TNBC-BL1-vs-TNBC-M |
7.137288E-01 |
| TNBC-BL1-vs-TNBC-MSL |
4.386686E-01 |
| TNBC-BL1-vs-TNBC-UNS |
1.521789E-01 |
| TNBC-BL2-vs-TNBC-LAR |
5.541181E-01 |
| TNBC-BL2-vs-TNBC-IM |
9.479889E-01 |
| TNBC-BL2-vs-TNBC-M |
9.774301E-01 |
| TNBC-BL2-vs-TNBC-MSL |
5.728826E-01 |
| TNBC-BL2-vs-TNBC-UNS |
2.626127E-01 |
| TNBC-LAR-vs-TNBC-IM |
4.993215E-01 |
| TNBC-LAR-vs-TNBC-M |
4.888754E-01 |
| TNBC-LAR-vs-TNBC-MSL |
3.226063E-01 |
| TNBC-LAR-vs-TNBC-UNS |
1.451342E-01 |
| TNBC-IM-vs-TNBC-M |
9.567521E-01 |
| TNBC-IM-vs-TNBC-MSL |
5.866406E-01 |
| TNBC-IM-vs-TNBC-UNS |
2.251927E-01 |
| TNBC-M-vs-TNBC-MSL |
5.419130E-01 |
| TNBC-M-vs-TNBC-UNS |
1.199404E-01 |
| TNBC-MSL-vs-TNBC-UNS |
7.966821E-01 |
|
|
